Implanted automatic defibrillators: effects of drugs and pacemakers.

The automatic implantable cardioverter defibrillator is an effective device for prevention of sudden ire device for prevention of sudden cardiac death. Patients who require the implantation of the device often require permanent pacing for symptomatic bradyarrhythmias and may require antiarrhythmic d...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 11; no. 12; pp. 2250 - 2263
Autores principales: Singer I, Guarnieri T, Kupersmith J
Formato: Journal Article
Publicado: Wiley-Blackwell Dec1988
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106087409&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106087409
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Dec1988
      vid: 11
      iid: 12
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        106087409
        2009414416
        NLM2463613
        106087409
      ppf: 2250
      ppct: 13
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Implanted automatic defibrillators: effects of drugs and pacemakers.
      aug:
        au:
          Singer I
          Guarnieri T
          Kupersmith J
      sug:
        subj:
          Antiarrhythmia Agents Therapeutic Use
          Arrhythmia Prevention and Control
          Cardioversion Equipment and Supplies
          Death, Sudden
          Pacemaker, Artificial
          Ventricular Fibrillation Prevention and Control
          Combined Modality Therapy
          Electrodes, Implanted
      ab: The automatic implantable cardioverter defibrillator is an effective device for prevention of sudden ire device for prevention of sudden cardiac death. Patients who require the implantation of the device often require permanent pacing for symptomatic bradyarrhythmias and may require antiarrhythmic drug therapy. Antiarrhythmic drugs may alter the defibrillation thresholds, arrhythmia cycle length and frequency, pacing thresholds and postshock excitability. Interactions between the defibrillator and the pacemaker may result in sensing problems, leading to multiple counting and inappropriate shocks, or ventricular fibrillation nondetection, sensing or capture failure post defibrillation and pacemaker reprogramming induced by defibrillator discharge. The potential for interactions will increase as the new generation of programmable defibrillators become clinically available, combining features of permanent pacemakers, antitachycardia pacemakers and defibrillators.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N